Results 191 to 200 of about 166,968 (308)
ABSTRACT Aims To summarize current evidence on β3‐adrenoceptor agonists for managing neurogenic lower urinary tract dysfunction (NLUTD), focusing on their efficacy, safety, and clinical role in optimizing bladder storage and protecting upper tracts. Methods Evidence from randomized controlled trials, meta‐analyses, and observational studies in spinal ...
Sharon E. Fishberg, Rano Matta
wiley +1 more source
Barriers & Facilitators to Help-Seeking Behaviour for Abnormal Lower Urinary Tract Symptoms in Men: Systematic Review. [PDF]
McIntosh S +4 more
europepmc +1 more source
ABSTRACT Aims To explore the boundary of clinical use of sacral nerve stimulation (SNS) in neurogenic lower urinary tract dysfunction (NLUTD), identifying barriers to approval and early‐impact research questions. Methods This review is derived from a proposal discussion at the International Consultation on Incontinence‐Research Society in Bristol in ...
Marcus J. Drake +6 more
wiley +1 more source
Analysis of the onset of lower urinary tract symptoms in multiple scleroris patients. [PDF]
Krhut J +8 more
europepmc +1 more source
Which Patients With Dysfunctional Voiding Respond Well to Sacral Neuromodulation? ICI‐RS 2025
ABSTRACT Aims Dysfunctional voiding (DV) is characterised by fluctuating or intermittent urinary flow during voiding in neurologically normal individuals. Given the different definitions used and heterogeneous pathophysiologies, outcomes following sacral neuromodulation/sacral nerve stimulation (SNM/SNS) are variably reported.
Jalesh N. Panicker +8 more
wiley +1 more source
Association of Sarcopenic Obesity with Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms: A Nationwide Cross-sectional Study. [PDF]
Zhou Z, Liu G, Ji J, Liu Y, Liao L.
europepmc +1 more source
Pathophysiology of nocturnal lower urinary tract symptoms in older patients with urinary incontinence [PDF]
Marie‐Astrid Denys +5 more
openalex +1 more source
ABSTRACT Introduction Artificial intelligence (AI) is poised to improve the diagnosis and management of lower urinary tract dysfunction (LUTD). Its effective deployment requires prioritization, regulatory oversight, rigorous validation, and clinician and patient engagement.
Glenn T. Werneburg +15 more
wiley +1 more source
Psychosocial risk and protective factors for men's lower urinary tract symptoms: A secondary analysis of CARDIA cohort study data. [PDF]
Brady SS +9 more
europepmc +1 more source

